UNICREDIT BANK/CALL/BIOGEN IDEC/300/0.1/18.06.25 Share Price

Warrant

DE000HC96FC9

Market Closed - BOERSE MUENCHEN 01:10:49 29/06/2024 am IST
1.5 EUR +1.35% Intraday chart for UNICREDIT BANK/CALL/BIOGEN IDEC/300/0.1/18.06.25
Current month+2.74%
1 month+17.19%
Date Price Change
28/24/28 1.5 +1.35%
27/24/27 1.48 +10.45%
26/24/26 1.34 +0.75%
25/24/25 1.33 -6.99%
24/24/24 1.43 +5.93%

Real-time BOERSE MUENCHEN

Last update June 29, 2024 at 01:10 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BIOGEN INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC96FC
ISINDE000HC96FC9
Date issued 11/09/2023
Strike 300 $
Maturity 18/06/2025 (353 Days)
Parity 10 : 1
Emission price 3.81
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 4.45
Lowest since issue 0.7
Delta0.35x
Omega 4.879
Premium36.66x
Gearing13.79x
Moneyness 0.7727
Difference Strike 68.18 $
Difference Strike %+22.73%
Spread 0.02
Spread %1.27%
Theoretical value 1.580
Implied Volatility 37.23 %
Total Loss Probability 77.02 %
Intrinsic value 0.000000
Present value 1.580
Break even 316.92 €
Theta-0.04x
Vega0.08x
Rho0.06x

Company Profile

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (17,2%) ; - other (9,1%): primarily revenues from partnership agreements.
Sector
-
More about the company

Ratings for Biogen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Biogen Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
231.8 USD
Average target price
283.2 USD
Spread / Average Target
+22.14%
Consensus